Novo A/S Acquires Xellia Pharmaceuticals for US$ 700 million

News   May 21, 2013

 
Novo A/S Acquires Xellia Pharmaceuticals for US$ 700 million
 
 
 
FURTHER INFORMATION
 

This content appears on:

Biopharma

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

Comments | 0 ADD COMMENT